Part I. Bcl-2 and Bcl-X(L) limit apoptosis upon infection with alphavirus vectors

Biotechnology and Bioengineering

Volumn 67, Issue 5, 2000, Pages 544-554

  Mastrangelo, Alison J ^a,d   Hardwick, J Marie ^b   Bex, Françoise ^c   Betenbaugh, Michael J ^a  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d NEW ENGLAND BIOLABS   (United States)

Author keywords

Apoptosis; Chloramphenicol acetyltransferase; Interleukin 12; Mammalian cell culture; Semliki Forest virus; Sindbis virus

Indexed keywords

CELL IMMOBILIZATION; ENZYMES; GENES; VIRUSES;

CHLORAMPHENICOL ACETYLTRANSFERASE; INTERLEUKIN GENES; SEMLIKI FOREST VIRUS; SINDBIS VIRUS;

GENETIC ENGINEERING;

PROTEIN BCL 2; VIRUS VECTOR;

ALPHA VIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; NONHUMAN; SINDBIS VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION;

ALPHAVIRUS; ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA; RABBIT FIBROMA VIRUS; RNA VIRUSES; SEMLIKI FOREST VIRUS; SINDBIS VIRUS;

EID: 0034607156     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0290(20000305)67:5<544::aid-bit5>3.0.co;2-%23     Document Type: Article

References (27)

1. Barr PJ, Tomei LD. 1994. Apoptosis and its role in human diesease. Bio/ Technology 12:487-493.
2. 1. Nature 379: 554-556.
3. Curling EMA, Hayter PM, Baines AJ, Bull AT, Gull K, Strange PG, Jenkins N. 1990. Recombinant human interferon-y: différences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. Biochem J 272:333-337.
4. Duke RC, Ojcius DM, Young JD-E. 1996. Cell suicide in health and disease. Sci Am December 1996:80-87.
5. Flexner C, Hugin A, Moss B. 1987. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression. Nature 330:259-262.
6. Griffin DE. 1986. Alphavirus pathogenesis and immunity. In: Schlesinger S, Schlesinger MJ, editors. The togaviridae and flaviviridae. New York: Plenum Press. p 209-251.
7. Hardwick JM. 1997. Virus-induced apoptosis. Adv Pharmacol 41: 295-336.
8. Itoh Y, Ueda H, Suzuki E. 1995. Overexpression of bcl-2, apoptosis suppressing gene: prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng 48:118-122.
9. Kaufman RJ, Wasley LC, Spiliotes AJ, Gossels SD, Latt SA, Larsen GR, Kay RM. 1985. Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells. Mol Cell Biol 5:1750-1759.
10. Kerr JFR, Wyllie AH, Currie AR. 1972. Apoptosis: a basic biological phenomena with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
11. Laub O, Rutter WJ. 1983. Expression of the human insulin gene and cDNA in a heterologous mammalian system. J Biol Chem 258:6043-6050.
12. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361:739-742.
13. Liljeström P, Garoff H. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 9:1356-1361.
14. Lundstrom K, Pralong W, Martinou J-C. 1997. Anti-apoptotic effect of Bcl-2 overexpression in RIN cells infected with Semliki Forest virus. Apoptosis 2:189-191.
15. Mastrangelo AJ, Hardwick JM, Belenbaugh MJ. 1996. Bcl-2 inhibits apoptosis and extends recombinant protein production in cells infected with Sindbis viral vectors. Cytotechnology 22:169-178.
16. Mastrangelo AJ, Zou S, Hardwick JM, Betenbaugh MJ. 1999. Antiapoptosis chemicals prolong productive lifetimes of mammalian cells upon Sindbis virus vector infections. Biotechnol Bioeng 65:298-305.
17. Mesner PW, Kaufman SH. 1997. Methods utilized in the study of apoptosis. Adv Pharmacol 41:56-81.
18. O'Reilly DR, Miller LK, Luckow VA. 1992. Baculovirus expression vectors: a laboratory manual. New York: W. H. Freedman and Company.
19. Peters C, Dalrymple J. 1990. Alphaviruses. In: Fields B, Knipe K, editors. Virology. 2nd edition. New York: Raven Press, Ltd. p 713-761.
20. Sambrook J, Hanahan D, Rodgers L, Gething MJ. 1986. Expression of human tissue-type plasminogen activator from lytic viral vectors and established cell lines. Mol Biol Med 3:459-481.
21. Schwartz LM, Osbourne BA. 1993. Programmed cell death, apoptosis and killer genes. Immun Today 14:582-590.
22. Singh RP, Emery AN, Al-Rubeai M. 1996. Enhancement of survivability of mammalian cells by overexpression of the apoptosis-suppressor gene bcl-2. Biotechnol Bioeng 52:166-175.
23. Stollar V. 1980. Togaviruses in cultured arthropod cells. In: Schlesinger RW, editor. The togaviruses. New York: Academic Press. p 583-621.
24. Suzuki E, Terada S, Ueda H, Fujita T, Komatsu T, Takayama S, Reed JC. 1997. Establishing apoptosis resistant cell lines for improving protein productively of cell culture. Cytotechnology 23:55-59.
25. Vaux DL, Weissman IL. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440-442.
26. Watson E, Bhide A, van Halbeek H. 1994. Structure determination of the intact major sialylated oligosaccharide chains of recominant human erythropoietin expressed in Chinese hamster ovary cells. Glycobiology 4:227-237.
27. Zhang J, Asselin-Paturel C, Bex F, Chehimi J, Willems F, Caignard A, Berglund P, Liljeström P, Burny A, Chouaib S. 1997. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells. Gene Therapy 4:367-374.